期刊文献+

经心包内全肺切除治疗中央型肺癌40例分析 被引量:2

Analysis of pneumonectomy via intrapericardial vascular management in the treatment of central lung cancer (a report of 40 cases)
下载PDF
导出
摘要 目的 总结全肺切除术治疗中央型肺癌的临床经验,探讨经心包内全肺切除的治疗价值.方法 2003年-2005年 行心包内全肺切除40例(部分左心房切除5例);鳞癌17例,腺癌8例,腺鳞癌5例,小细胞未分化癌10例;常规进行系统淋巴结清扫.结果 本组无围手术期死亡病例,术后1年、3年、5年生存率分别为65.0%(26/40)、37.5%(15/40)、17.5%(7/40),其中4例生存超过6年.结论 经心包内全肺及部分左心房切除术可提高中央型肺癌根治性手术的切除率,降低术中大出血的风险性. Objective To summarize the clinical experience in 40 cases of central lung cancer undergoing total pneumonectomy and to investigate the therapeutic value of total pneumonectomy via intrapericardial vascular management in the treatment Of central lung cancer. Methods From January 2003 to December 2005, 40 patients with central lung cancer were surgically treated with total pneumonectomy via intrapericardial vascular management (combined with partial resection of left atrium in 5 cases) in our hospital. There were 17 cases of squamous cell carcinoma, 8 cases of adnoearcinoma, 5 cases of adenosquamous carcinoma and 10 cases of smallcell undifferentiated carcinoma; and systematic lymph node dissection was performed. Results There was no perioperative death. The survival rate of 1, 3 and 5 years after surgery was 65.0%, 37.5% and 17.5%, respectively, of which 4 case survived for over 6 years. Conclusion Total pneumonectomy via intrapericardial vascular management combined with partial resection of left atrium could increase the resection rate in the radical surgery for central lung cancer and decrease the risk of intraoperative hemorrhage.
出处 《徐州医学院学报》 CAS 2011年第4期245-246,共2页 Acta Academiae Medicinae Xuzhou
关键词 中央型肺癌 全肺切除术 心包内处理肺血管 central lung cancer pneumonectomy treating pulmonary blood vessels in pericardium
  • 相关文献

参考文献5

二级参考文献53

  • 1张逊,王增林,姚计方,杜喜群,陈东鸿,陈宇.全肺切除治疗原发性支气管肺癌125例临床分析[J].中华胸心血管外科杂志,1995,11(4):250-251. 被引量:8
  • 2张效公 黄孝迈 等.肺癌及其它恶性肿瘤.现代胸外科学(第2版)[M].北京:人民军医出版社,1997.350.
  • 3周清华,华西医学,1993年,8卷,366页
  • 4周清华,中华肿瘤杂志,1993年,15卷,388页
  • 5Alexander E, Moriarty T M, Davis R B, et al. Stereotactic radiosurgery for the definitive, non-invasive treatment of brain metastases [J]. J Natl Cancer Inst, 1995,87:34 - 40
  • 6Arita T, Kuramitsu T, Kawamura M, et al. Bronchogenic carcinoma: Incidence of metastases to normal sized lymph nodes [J]. Thorax, 1995,50:1267 - 1269
  • 7Bonomi P, Faber L: Neoadjuvant chemoradiation therapy in NSCLC: The Rush University experience [J]. Lung Cancer, 1993,9:383 - 390
  • 8Burkes R, Ginsberg R, Shephard F, et al. Induction chemotherapy with mitomycin, vindesine and cisplatin for unresectable non-small cell lung cancer: Results of the Toronto phase Ⅱ trial [J]. J Clin Oncol, 1992,10:580 - 586
  • 9Burt M, Wronski M, Galicich J, Martini N, Ginsberg R(Members of the Memorial Sloan-Kettering Cancer Center Thoracic and Neurosurgical Services). Solitary brain metastases from non-small cell lung cancer: Results of therapy. Presented at the 71st Annual Meeting of the American Association for Thoracic Surgery,Washington DC, May 6 - 8, 1991
  • 10Chin R, Ward R, Keys J W. Mediastinal staging of non-small cell lung cancer with positron emission tomography [J]. Am J Respir Crit Care Med, 1995,152:2090 - 2096

共引文献80

同被引文献18

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部